Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2021

Month: April

Request Number: A-2017-000369

Request Summary: All reviewers' reports regarding the cleared New Drug Submission (NDS) for ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated] Manufactured by Baxalta.

Disposition: Disclosed in part

Number of pages: 152

Date modified: